CIK 0001515673
- Large accelerated filer
Ultragenyx Pharmaceutical Inc.
Sign in to watch- Ticker
- RARE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272546083
- Phone
- +1 415-483-8800
- Business address
- 60 LEVERONI COURT, NOVATO, CA, 94949
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $127,561
- in 3 filings, $17K under 10b5-1 plans
Net −$127,561. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-08 | Huizenga Theodore Alan SVP, Controller and PAO | Exercise or conversion | +2,000 | $21.00 | $42K | 18,582 |
| 2020-07-08 | Huizenga Theodore Alan SVP, Controller and PAO | Sale | −2,000 | $91.00 | $182K | 16,582 |
| 2020-07-08 | Huizenga Theodore Alan SVP, Controller and PAO | Exercise or conversion · Stock Option (Right to Buy) | −2,000 | 12,000 | ||
| 2020-07-06 | Fust Matthew K Director | Exercise or conversion | +6,181 | $21.00 | $130K | 19,731 |
| 2020-07-06 | Fust Matthew K Director | Sale | −6,181 | $90.00 | $556K | 13,550 |
| 2020-07-06 | Fust Matthew K Director | Exercise or conversion · Stock Option (Right to Buy) | −6,181 | 0 | ||
| 2020-07-06 | Harris Erik EVP & Chief Commercial Officer | Shares withheld for taxes | −260 | $86.75 | $23K | 23,590 |
| 2020-07-01 | Fust Matthew K Director | Exercise or conversion | +5,000 | $21.00 | $105K | 18,550 |
| 2020-07-01 | Fust Matthew K Director | Sale | −5,000 | $85.00 | $425K | 13,550 |
| 2020-07-01 | Fust Matthew K Director | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 6,181 | ||
| 2020-07-01 | Huizenga Theodore Alan SVP, Controller and PAO | Sale | −1,111 | $81.00 | $90K | 17,220 |
| 2020-07-01 | Huizenga Theodore Alan SVP, Controller and PAO | Exercise or conversion | +1,500 | $21.00 | $32K | 18,720 |
| 2020-07-01 | Huizenga Theodore Alan SVP, Controller and PAO | Sale | −1,500 | $81.00 | $122K | 17,220 |
| 2020-07-01 | Huizenga Theodore Alan SVP, Controller and PAO | Exercise or conversion · Stock Option (Right to Buy) | −1,500 | 14,000 | ||
| 2020-06-26 | WELCH DANIEL G Director | Grant or award | +2,550 | 12,300 | ||
| 2020-06-26 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2020-06-26 | SULIMAN SHEHNAAZ Director | Grant or award | +2,550 | 5,550 | ||
| 2020-06-26 | SULIMAN SHEHNAAZ Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 | ||
| 2020-06-26 | SIEGALL CLAY B Director | Grant or award | +2,550 | 12,300 | ||
| 2020-06-26 | SIEGALL CLAY B Director | Grant or award · Stock Option (Right to Buy) | +4,250 | 4,250 |
Page 26 of 32 · 632 trades